Literature DB >> 20585035

Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

Ioanna Skountzou1, Dimitrios G Koutsonanos, Jin Hyang Kim, Ryan Powers, Lakshmipriyadarshini Satyabhama, Feda Masseoud, William C Weldon, Maria Del Pilar Martin, Robert S Mittler, Richard Compans, Joshy Jacob.   

Abstract

The 2009 H1N1 influenza virus outbreak is the first pandemic of the twenty-first century. Epidemiological data reveal that of all the people afflicted with H1N1 virus, <5% are over 51 y of age. Interestingly, in the uninfected population, 33% of those >60 y old have pre-existing neutralizing Abs against the 2009 H1N1 virus. This finding suggests that influenza strains that circulated 50-60 y ago might provide cross-protection against the swine-origin 2009 H1N1 influenza virus. To test this, we determined the ability of representative H1N1 influenza viruses that circulated in the human population from 1930 to 2000, to induce cross-reactivity to and cross-protection against the pandemic swine-origin H1N1 virus, A/California/04/09. We show that exposure of mice to the 1947 virus, A/FM/1/47, or the 1934 virus, A/PR/8/34, induced robust cross-protective immune responses and these mice were protected against a lethal challenge with mouse-adapted A/California/04/09 H1N1 virus. Conversely, we observed that mice exposed to the 2009 H1N1 virus were protected against a lethal challenge with mouse-adapted 1947 or 1934 H1N1 viruses. In addition, exposure to the 2009 H1N1 virus induced broad cross-reactivity against H1N1 as well as H3N2 influenza viruses. Finally, we show that vaccination with the older H1N1 viruses, particularly A/FM/1/47, confers protective immunity against the 2009 pandemic H1N1 virus. Taken together, our data provide an explanation for the decreased susceptibility of the elderly to the 2009 H1N1 outbreak and demonstrate that vaccination with the pre-1950 influenza strains can cross-protect against the pandemic swine-origin 2009 H1N1 influenza virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585035      PMCID: PMC4457446          DOI: 10.4049/jimmunol.1000091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.

Authors:  R J Russell; S J Gamblin; L F Haire; D J Stevens; B Xiao; Y Ha; J J Skehel
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

2.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

3.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

5.  Evidence of a cross-protective immune response to influenza A in the cotton rat model.

Authors:  Timothy M Straight; Martin G Ottolini; Gregory A Prince; Maryna C Eichelberger
Journal:  Vaccine       Date:  2006-06-13       Impact factor: 3.641

6.  Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection.

Authors:  Paul P Heinen; Els A de Boer-Luijtze; Andre T J Bianchi
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

Review 7.  Swine influenza virus infections in humans.

Authors:  W R Dowdle; M A Hattwick
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

8.  Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases.

Authors:  J C Gaydos; R A Hodder; F H Top; V J Soden; R G Allen; J D Bartley; J H Zabkar; T Nowosiwsky; P K Russell
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

9.  Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes.

Authors:  P Palese; J L Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Authors:  Amorsolo L Suguitan; Josephine McAuliffe; Kimberly L Mills; Hong Jin; Greg Duke; Bin Lu; Catherine J Luke; Brian Murphy; David E Swayne; George Kemble; Kanta Subbarao
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

View more
  59 in total

1.  Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.

Authors:  Yuan Fang; David Banner; Alyson A Kelvin; Stephen S H Huang; Christopher J Paige; Steven A Corfe; Kevin P Kane; R Chris Bleackley; Thomas Rowe; Alberto J Leon; David J Kelvin
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

2.  Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

Authors:  Sanae Sasaki; Meghan Sullivan; Carlos F Narvaez; Tyson H Holmes; David Furman; Nai-Ying Zheng; Madhuri Nishtala; Jens Wrammert; Kenneth Smith; Judith A James; Cornelia L Dekker; Mark M Davis; Patrick C Wilson; Harry B Greenberg; Xiao-Song He
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

3.  Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Authors:  Susanne L Linderman; Benjamin S Chambers; Seth J Zost; Kaela Parkhouse; Yang Li; Christin Herrmann; Ali H Ellebedy; Donald M Carter; Sarah F Andrews; Nai-Ying Zheng; Min Huang; Yunping Huang; Donna Strauss; Beth H Shaz; Richard L Hodinka; Gustavo Reyes-Terán; Ted M Ross; Patrick C Wilson; Rafi Ahmed; Jesse D Bloom; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 4.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

5.  Epidemiology of influenza A (H1N1)pdm09-associated deaths in the United States, September-October 2009.

Authors:  Joanna Regan; Ashley Fowlkes; Matthew Biggerstaff; Michael A Jhung; Jacqueline Gindler; Erin Kennedy; Victoria Fields; Lyn Finelli
Journal:  Influenza Other Respir Viruses       Date:  2012-07-16       Impact factor: 4.380

6.  Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.

Authors:  Maria E Lorenzo; Andrea Hodgson; Dionne P Robinson; Jenifer B Kaplan; Andrew Pekosz; Sabra L Klein
Journal:  Vaccine       Date:  2011-10-06       Impact factor: 3.641

7.  Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect.

Authors:  F Eun-Hyung Lee; Jessica L Halliley; Edward E Walsh; Andrew P Moscatiello; Brittany L Kmush; Ann R Falsey; Troy D Randall; Denise A Kaminiski; Richard K Miller; Iñaki Sanz
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

8.  Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.

Authors:  Elena V Vassilieva; Haripriya Kalluri; Devin McAllister; Misha T Taherbhai; E Stein Esser; Winston P Pewin; Joanna A Pulit-Penaloza; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

Review 9.  Targeting the skin for microneedle delivery of influenza vaccine.

Authors:  Dimitrios G Koutsonanos; Richard W Compans; Ioanna Skountzou
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Authors:  Junwei Li; Maria T Arévalo; Yanping Chen; Shan Chen; Mingtao Zeng
Journal:  Int J Infect Dis       Date:  2014-08-27       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.